Ia. Bergdahl et al., LEAD BINDING TO DELTA-AMINOLEVULINIC-ACID DEHYDRATASE (ALAD) IN HUMANERYTHROCYTES, Pharmacology & toxicology, 81(4), 1997, pp. 153-158
Over 99% of the lead present in blood is usually found in erythrocytes
. To investigate the nature of this selective accumulation of lead in
erythrocytes, the specific binding of lead to proteins in human erythr
ocytes was studied using liquid chromatography coupled to inductively
coupled plasma mass spectrometry (LC-ICP-MS). The principal lead-bindi
ng protein had a mass of approximately 240 kDa, and adsorption to spec
ific antibodies showed that the protein was delta-aminolevulinic acid
dehydratase (ALAD). Thus, the previous notion that lead in erythrocyte
s was bound primarily to haemoglobin has to be revised. Furthermore, i
n lead-exposed workers, the percentage of lead bound to ALAD was influ
enced by a common polymorphism in the ALAD gene. Specifically, in seve
n carriers of the ALAD(2) allele, 84% of the protein-bound lead recove
red was bound to ALAD compared to 81% in seven homozygotes for the ALA
D(1) allele whose erythrocytes were matched for blood-lead concentrati
on. The small difference was statistically significant in Wilcoxon mat
ched-pairs signed-rank test (P=0.03). No ALAD allele-specific differen
ce in ALAD-bound lead was found among 20 unexposed controls. Perhaps t
he difference in ALAD-bound lead can provide an explanation for the pr
eviously reported finding of higher blood-lead levels among carriers o
f the ALAD(2) allele than among ALAD(1) homozygotes in lead-exposed po
pulations.